Budas, Haniyya .

HRN: 26-27-63  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2025
CEFUROXIME 750MG (VIAL)
09/22/2025
09/29/2025
IV
300 Mg
Q 8 Hours
PCAP-C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines